Abstract

Cross-linking mass spectrometry (MS) is currently transitioning from a routine tool in structural biology to enabling structural systems biology. MS-cleavable cross-linkers could substantially reduce the associated search space expansion by allowing a MS3-based approach for identifying cross-linked peptides. However, MS2 (MS/MS)-based approaches currently outperform approaches utilizing MS3. We show here that the sensitivity and specificity of triggering MS3 have been hampered algorithmically. Our four-step MS3-trigger algorithm greatly outperformed currently employed methods and comes close to reaching the theoretical limit.
Cross-linking mass spectrometry (cross-linking MS) is a discovery tool of hitherto hidden aspects of biology,1 from placing protein sequence in unassigned densities of cryoEM and cryoET data2 to capturing weak interactions in whole cells that are lost upon lysis.3 Among the plethora of cross-linking MS workflows,4−6 the use of MS-cleavable cross-linkers stands out.7−12 Their cleavage reverses the cross-link in the mass spectrometer, such that the two peptides can be analyzed individually. While this can also be achieved computationally during data analysis,13 doing so in the mass spectrometer improves peptide fragmentation.14 Accordingly, cleavable cross-linkers improve the number of reliably identifiable cross-links, especially in complex samples.14,15 In principle, the unlinked peptides could also be selected for separate fragmentation in MS3.16 MS3 would tremendously simplify data analysis; however, most investigations focus on MS2 (MS/MS) data.17,18 The additional acquisition time cost due to the acquisition of MS3 spectra is one of the downsides of MS3-based approaches14,19 which would need to be counterbalanced by clear advantages. However, MS3 approaches based on MS-cleavable cross-linkers are currently limited by two technical challenges:14 while the signature doublets of the two peptides can routinely be detected in the spectra of cross-linked peptides (81%), only 41% of the individual peptides are selected for MS3 due to low sensitivity. In addition, much time is wasted on MS3 of non-cross-linked peptides that are present at higher abundance in the analyzed samples (i.e., low specificity). This is the problem with current algorithms used for MS3 decision making, and we present here a novel algorithm for MS3-based acquisition strategies.
We first designed a four-step procedure that we felt was highly likely to improve results based on our previous analysis.20 First, isotopic envelopes in the spectrum are detected, deconvoluted to give monoisotopic peaks with summed intensities, and assigned charge states (Figure 1a). Second, for each peak with a defined charge state, its theoretical doublet partner peak is calculated by the addition of the doublet delta mass divided by the charge state. These theoretical doublet peaks are then matched against peaks with matching charge states, considering a user-defined relative m/z tolerance (Figure 1b). Third, a rank-based cutoff is applied, and all doublets with a rank smaller than 20 are disregarded, to reduce noise matching (Figure 1c). Fourth, we implemented a “second peptide mass” filter, eliminating doublets that leave less than 500 Da for the second peptide. This results in a final matched-doublet list (Figure 1d). If the remaining mass is less than 500 Da, no MS3 should be acquired because the doublet stems either from a linear peptide with a cross-linker modification, is a false-positive random match, or the second peptide is too small to be reliably identifiable (Figure S1). We chose 5 ppm as the mass tolerance for matching the doublet delta mass, based on accuracy of the data and balancing specificity and selectivity (Figure S2).
Figure 1.
Improved MS3-trigger algorithm for MS2 spectra. (a) General MS3-based workflow of MS-cleavable cross-linkers. MS3 of individual peptides is triggered based on MS2-cleavage of the cross-linked peptide pair, using doublet signals resulting from the asymmetric cross-linker cleavage (adapted from O’Reilly and Rappsilber4). (b–e) Flowchart of the improved MS3-trigger algorithm for MS2 spectra. (b) Deconvolution of isotope clusters and charge determination. (c) Doublet matching by Δm and charge state. (d) Doublets must have at least one doublet peak among the top 20 peaks ranked by intensity (intensity rank filter). (e) The mass difference between a doublet and the precursor mass is required to be >500 Da (second peptide mass filter). This excludes linear peptides that are modified with a cross-linker and therefore lead to doublets in MS2. The filter also excludes cross-linked peptides with a second peptide that is too short for reliable identification.
Next, we tested the algorithm on two publicly available data sets that utilized MS3-based acquisition methods, the Ribosome21 and Synaptosome22 data sets. Each matched doublet from the final output of our algorithm would have triggered the acquisition of a MS3 spectrum. We evaluated this against MS3 actually triggered during the acquisition with regard to specificity and sensitivity. With respect to sensitivity, for the best-case scenario, we would expect to trigger an MS3 for a doublet of every peptide that we found by annotating the identified cross-link-spectrum matches (CSMs). This gives a theoretically possible maximum of 85% of all CSMs for the Synaptosome data set (Figure 2a) and 76% for the Ribosome data set (Figure 2d). The rate of correctly triggered doublets improved on both peptide doublets from 58% to 79% and from 37% to 60% of CSMs for the Synaptosome and Ribosome data sets, respectively, thus approaching the theoretical maximum (Figure 2b, e). In addition, our doublet selection algorithm vastly improved the specificity in both data sets (Figure 2c, f). We were able to almost completely eliminate MS3 spectra triggered by linear peptide–spectrum matches (PSMs) (−92%). On average, only 0.11 and 0.09 of MS3 spectra were triggered per MS2 spectrum in the Synaptosome and Ribosome data sets, respectively, by these non-cross-linked peptides. In addition, MS3 spectra triggered by cross-linker-modified linear peptides were also reduced substantially, by approximately 75% on average.
Figure 2.
Sensitivity and specificity of MS3 triggering. (a, d) Proportion of identified cross-linked-spectrum matches (CSMs) that contain one (lighter colors) or both (darker colors) peptide doublets in each data set (5% CSM-level FDR). (b, e) Proportion of correctly triggered MS3 scans, comparing data from acquisitions to the results of the xiDOUBLET algorithm. (c, f) Number of triggered MS3 scans per MS2 scan, comparing data from acquisitions to the xiDOUBLET algorithm. Ideally, two MS3 scans are triggered for a cross-link (one for each of the two peptides, dotted line) and none for linear and modified linear peptides. Error bars show the 0.95 confidence interval. Panels (a–c) represent the Synaptosome, panels (d–f) the Ribosome data.
Gains in sensitivity and time during acquisition in addition to gains in selectivity greatly affect the depth of the analysis. We have demonstrated here that sensitivity and specificity can be improved considerably with no change in the experimental design of established cross-linking MS protocols. Our four-step procedure vastly outperforms the doublet selection algorithm currently employed on Orbitrap mass spectrometers. The closed source code of the instrument control software prevents us from implementing our procedure on Orbitraps, however, making a case for open-source code in the interest of scientific progress. We therefore extend an urgent call to the vendor to implement the improved procedure on Orbitraps. Our work shows, nonetheless, that MS3 approaches suffer from algorithmic restrictions that can be overcome and that overcoming these restrictions will help to unfold the full potential of MS-cleavable cross-linkers for structural proteomics. Once these improvements are implemented, it will be interesting to repeat direct comparisons with stepped-HCD MS2, the currently best performing acquisition strategy for cross-linked peptides.20,21
Experimental Section
We reanalyzed the publicly available CID MS3-based data from the Ribosome data set (PXD011861) and Synaptosome (PXD010317 and PXD015160) data set. The data sets were analyzed as previously described.14 A 5% CSM level FDR, with sequence-consecutive and minimum peptide length (5 amino acids) filters, was applied. The CID spectra were annotated using pyXiAnnotator according to the CSM identification. We annotated the b- and y-ion series and the cleavable cross-linker stub fragments A, S, and T using a 15 ppm fragment mass tolerance. For the doublet rank evaluation, the “deisotoped max rank” column from the pyXiAnnotator output (which determines the rank of the annotated isotope cluster by comparing the maximum intensity peak of each isotope cluster) was used. A doublet rank was then assigned based on the higher of the two doublet peak ranks. To determine if the correct peaks were being triggered for MS3, the MS3 precursor m/z was extracted from the scan header of the MS3 spectra associated with the unique CSMs passing FDR (as described above) and compared with the corresponding MS2-CID annotation result. If the MS3 precursor matched a cross-linked peptide stub fragment within 20 ppm error tolerance, it was assigned as “correctly triggered”. For the evaluation of the MS3 trigger specificity, the number of MS3 scans associated with nonunique CSMs and linear PSMs (with and without hydrolyzed or amidated cross-linker modifications) which were above the FDR threshold was used.
The settings for the xiDOUBLET doublet detection algorithm used here were ms2_tol of 5 ppm tolerance, cross-linker DSSO, stubs A & T, rank_cutoff of 20, cap of 4, and second_peptide_mass_filter 500. The algorithm is written in Python and is open source and freely available on https://github.com/Rappsilber-Laboratory/xiDOUBLET.
Acknowledgments
This research was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany′s Excellence Strategy – EXC 2008 – 390540038 – UniSysCat and project 449713269. The Wellcome Centre for Cell Biology is supported by core funding from the Wellcome Trust (Grant number 203149). For the purpose of open access, the authors have applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.3c01673.
Distribution of second peptide masses (Figure S1) and sensitivity and specificity of MS3 triggering using different mass tolerances (Figure S2) (PDF)
Author Contributions
L.K. and J.R. designed the experiments. L.K and L.F. wrote the algorithm code. L.K. evaluated the data. L.K. and J.R. prepared figures and wrote the manuscript. All authors have given approval to the final version of the manuscript.
The authors declare no competing financial interest.
Supplementary Material
References
- Kustatscher G.; Collins T.; Gingras A.-C.; Guo T.; Hermjakob H.; Ideker T.; Lilley K. S.; Lundberg E.; Marcotte E. M.; Ralser M.; Rappsilber J. Understudied Proteins: Opportunities and Challenges for Functional Proteomics. Nat. Methods 2022, 19, 774. 10.1038/s41592-022-01454-x. [DOI] [PubMed] [Google Scholar]
- O’Reilly F. J.; Xue L.; Graziadei A.; Sinn L.; Lenz S.; Tegunov D.; Blötz C.; Singh N.; Hagen W. J. H.; Cramer P.; Stülke J.; Mahamid J.; Rappsilber J. In-Cell Architecture of an Actively Transcribing-Translating Expressome. Science 2020, 369 (6503), 554–557. 10.1126/science.abb3758. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O’Reilly F. J.; Graziadei A.; Forbrig C.; Bremenkamp R.; Charles K.; Lenz S.; Elfmann C.; Fischer L.; Stülke J.; Rappsilber J. Protein Complexes in Bacillus Subtilis by AI-Assisted Structural Proteomics. Molecular Systems Biology 2023, 19, e11544. 10.15252/msb.202311544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O’Reilly F. J.; Rappsilber J. Cross-Linking Mass Spectrometry: Methods and Applications in Structural, Molecular and Systems Biology. Nat. Struct. Mol. Biol. 2018, 25 (11), 1000–1008. 10.1038/s41594-018-0147-0. [DOI] [PubMed] [Google Scholar]
- Yu C.; Huang L. Cross-Linking Mass Spectrometry: An Emerging Technology for Interactomics and Structural Biology. Anal. Chem. 2018, 90 (1), 144–165. 10.1021/acs.analchem.7b04431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chavez J. D.; Bruce J. E. Chemical Cross-Linking with Mass Spectrometry: A Tool for Systems Structural Biology. Curr. Opin. Chem. Biol. 2019, 48, 8–18. 10.1016/j.cbpa.2018.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tang X.; Munske G. R.; Siems W. F.; Bruce J. E. Mass Spectrometry Identifiable Cross-Linking Strategy for Studying Protein-Protein Interactions. Anal. Chem. 2005, 77 (1), 311–318. 10.1021/ac0488762. [DOI] [PubMed] [Google Scholar]
- Kao A.; Chiu C.-L.; Vellucci D.; Yang Y.; Patel V. R.; Guan S.; Randall A.; Baldi P.; Rychnovsky S. D.; Huang L. Development of a Novel Cross-Linking Strategy for Fast and Accurate Identification of Cross-Linked Peptides of Protein Complexes. Mol. Cell. Proteomics 2011, 10 (1), M110.002170 10.1074/mcp.M110.002212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Müller M. Q.; Dreiocker F.; Ihling C. H.; Schäfer M.; Sinz A. Cleavable Cross-Linker for Protein Structure Analysis: Reliable Identification of Cross-Linking Products by Tandem MS. Anal. Chem. 2010, 82 (16), 6958–6968. 10.1021/ac101241t. [DOI] [PubMed] [Google Scholar]
- Lauber M. A.; Reilly J. P. Novel Amidinating Cross-Linker for Facilitating Analyses of Protein Structures and Interactions. Anal. Chem. 2010, 82 (18), 7736–7743. 10.1021/ac101586z. [DOI] [PubMed] [Google Scholar]
- Petrotchenko E. V.; Serpa J. J.; Borchers C. H. An Isotopically Coded CID-Cleavable Biotinylated Cross-Linker for Structural Proteomics. Mol. Cell. Proteomics 2011, 10 (2), M110.001420 10.1074/mcp.M110.001420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clifford-Nunn B.; Showalter H. D. H.; Andrews P. C. Quaternary Diamines as Mass Spectrometry Cleavable Crosslinkers for Protein Interactions. J. Am. Soc. Mass Spectrom. 2012, 23 (2), 201–212. 10.1007/s13361-011-0288-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giese S. H.; Fischer L.; Rappsilber J. A Study into the Collision-Induced Dissociation (CID) Behavior of Cross-Linked Peptides. Mol. Cell. Proteomics 2016, 15 (3), 1094–1104. 10.1074/mcp.M115.049296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kolbowski L.; Lenz S.; Fischer L.; Sinn L. R.; O’Reilly F. J.; Rappsilber J. Improved Peptide Backbone Fragmentation Is the Primary Advantage of MS-Cleavable Crosslinkers. Anal. Chem. 2022, 94 (22), 7779–7786. 10.1021/acs.analchem.1c05266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lenz S.; Sinn L. R.; O’Reilly F. J.; Fischer L.; Wegner F.; Rappsilber J. Reliable Identification of Protein-Protein Interactions by Crosslinking Mass Spectrometry. Nat. Commun. 2021, 12 (1), 3564. 10.1038/s41467-021-23666-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sinz A. Divide and Conquer: Cleavable Cross-Linkers to Study Protein Conformation and Protein-Protein Interactions. Anal. Bioanal. Chem. 2017, 409 (1), 33–44. 10.1007/s00216-016-9941-x. [DOI] [PubMed] [Google Scholar]
- Steigenberger B.; Albanese P.; Heck A. J. R.; Scheltema R. A. To Cleave or Not To Cleave in XL-MS?. J. Am. Soc. Mass Spectrom. 2020, 31 (2), 196–206. 10.1021/jasms.9b00085. [DOI] [PubMed] [Google Scholar]
- Matzinger M.; Vasiu A.; Madalinski M.; Müller F.; Stanek F.; Mechtler K. Mimicked Synthetic Ribosomal Protein Complex for Benchmarking Crosslinking Mass Spectrometry Workflows. Nat. Commun. 2022, 13 (1), 3975. 10.1038/s41467-022-31701-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klykov O.; Steigenberger B.; Pektaş S.; Fasci D.; Heck A. J. R.; Scheltema R. A. Efficient and Robust Proteome-Wide Approaches for Cross-Linking Mass Spectrometry. Nat. Protoc. 2018, 13 (12), 2964–2990. 10.1038/s41596-018-0074-x. [DOI] [PubMed] [Google Scholar]
- Kolbowski L.; Lenz S.; Fischer L.; Sinn L. R.; O’Reilly F. J.; Rappsilber J. Improved Peptide Backbone Fragmentation Is the Primary Advantage of MS-Cleavable Crosslinkers. Anal. Chem. 2022, 94, 7779. 10.1021/acs.analchem.1c05266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stieger C. E.; Doppler P.; Mechtler K. Optimized Fragmentation Improves the Identification of Peptides Cross-Linked by MS-Cleavable Reagents. J. Proteome Res. 2019, 18 (3), 1363–1370. 10.1021/acs.jproteome.8b00947. [DOI] [PubMed] [Google Scholar]
- Gonzalez-Lozano M. A.; Koopmans F.; Sullivan P. F.; Protze J.; Krause G.; Verhage M.; Li K. W.; Liu F.; Smit A. B. Stitching the Synapse: Cross-Linking Mass Spectrometry into Resolving Synaptic Protein Interactions. Sci. Adv. 2020, 6 (8), eaax5783 10.1126/sciadv.aax5783. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


